Home › Pathology › Medulloblastoma: Pathology, Features and Molecular Groups
Medulloblastoma
*Medulloblastoma*
For medical students2 min readUpdated 2026-10-10
Medulloblastoma is a malignant embryonal tumor of the central nervous system requiring detailed knowledge of its histological features, pathways of dissemination, and molecular subgroups. This overview highlights key aspects of its pathology, clinical presentation, and prognostic criteria.
HistologyEmbryonal small round blue cell tumor
PrognosisAnaplasia and MYC amplification indicate poor prognosis
MetastasisLeptomeningeal seeding along the neuraxis
MarkersSpecific molecular subgroups and staining profiles
Histological Structure and Anaplasia
The tumor is characterized by densely packed small round blue cells with high mitotic activity and scant cytoplasm.
Classic and Desmoplastic variants: Show varying architectural features, such as nodular reticulin-free zones in the desmoplastic/nodular variant.
Large Cell/Anaplastic variant: Characterized by nuclear enlargement, prominent nucleoli, severe nuclear pleomorphism, high mitotic rates, and frequent apoptotic bodies.
The presence of anaplasia and specific molecular amplifications serve as critical adverse prognostic indicators.
Metastasis and Spread
Spread of the tumor primarily occurs via the cerebrospinal fluid (CSF):
Leptomeningeal dissemination: Tumor cells readily shed into the subarachnoid space, leading to seeding along the surface of the brain and spinal cord (neuraxis metastases).
Extraneural metastases: Though rare due to the blood-brain barrier, systemic metastasis can occasionally occur, typically involving bone, bone marrow, and lymph nodes.
Pathogenesis and Molecular Groups
Pathogenesis involves distinct signaling pathway dysregulations depending on the molecular subgroup. The disease is frequently associated with specific genetic syndromes and alterations:
SHH pathway activation: Often linked with PTCH1 or SUFU mutations (frequent in infants and adults).
WNT pathway activation: Characterized by CTNNB1 mutations, typically showing the most favorable prognosis.
Group 3 and Group 4: Non-WNT/non-SHH tumors; Group 3 often features MYC amplification and carries the worst prognosis.
Mnemonic
WNT Wins, SHH Skin (Gorlin), Group 3 Gets MYC (Bad prognosis), Group 4 is For kids (most common).
Frequently asked questions
Where is medulloblastoma typically localized in the brain?
Medulloblastoma typically arises from the roof of the fourth ventricle and involves the vermis of the cerebellum in the posterior cranial fossa. In infants, it can be more laterally located in the cerebellar hemispheres.
What is the primary pathway of medulloblastoma metastasis within the CNS?
Metastasis within the central nervous system occurs primarily via the cerebrospinal fluid pathways (leptomeningeal dissemination) throughout the neuraxis.
What are the four main molecular-genetic subgroups of medulloblastoma?
The four main molecular subgroups defined by WHO are:
WNT-activated (WNT)
SHH-activated (SHH)
Non-WNT/non-SHH Group 3 (Group 3)
Non-WNT/non-SHH Group 4 (Group 4)
From which embryonic cells does medulloblastoma originate?
Medulloblastoma is an embryonal neuroepithelial tumor believed to arise from precursor cells of the external granular layer of the cerebellum or neural stem cells surrounding the fourth ventricle.
Which genetic syndromes increase the risk of developing medulloblastoma?
Medulloblastoma is associated with several hereditary cancer predisposition syndromes, including:
Gorlin syndrome (basal cell nevus syndrome, linked to SHH)
Li-Fraumeni syndrome (TP53 mutations)
Turcot syndrome (APC or MMR genes)
Cowden syndrome
What macroscopic features are characteristic of a medulloblastoma tumor mass?
Macroscopically, medulloblastoma presents as a large, soft, pink-gray, well-demarcated midline cerebellar mass that often fills the fourth ventricle and frequently shows areas of necrosis and hemorrhage.
What are the main histological variants of medulloblastoma recognized by the WHO classification?
The WHO histological variants include:
Classic medulloblastoma
Desmoplastic/nodular medulloblastoma
Medulloblastoma with extensive nodularity (MBEN)
Large cell/anaplastic medulloblastoma
What histological feature worsens the prognosis in medulloblastoma?
The presence of anaplasia—characterized by nuclear enlargement, pleomorphism, hyperchromasia, and high mitotic activity—along with MYC amplification indicates a poor prognosis.
How does medulloblastoma typically metastasize within the CNS?
Medulloblastoma predominantly disseminates via the cerebrospinal fluid (CSF), leading to leptomeningeal seeding along the surfaces of the brain and spinal cord.
Which molecular subgroup has the best prognosis?
The WNT-activated subgroup has the most favorable prognosis, with long-term survival rates exceeding 90%.
Go deeper
Molecular pathology and targeted therapies in medulloblastoma
Epidemiology and age distribution across subgroups
Genetic abnormalities and syndrome associations
Neuroradiological imaging features (MRI characteristics)